NDC 53145-0319-02: Hongocura S Undecylenic Acid 20 mg/100mL Spray
This is a package of Hongocura S Undecylenic Acid 20 mg/100mL Spray from MENPER DISTRIBUTORS, INC., first listed with the FDA Apr 2020 and currently FDA-listed. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 53145-319-02 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 53145 labeler · 319 product · 02 package
- Package marketed since
- Apr 6, 2020
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2027
- Barcode (UPC-A, from the NDC)
- 3 5314531902 6
- FDA record last changed
- Oct 22, 2026
Other active recalls for Undecylenic Acid (different manufacturers) — 3 · tap to view
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
Hongocura S is a topical spray containing undecylenic acid, an OTC monograph product. Undecylenic acid is a fatty acid typically used in products meant to address fungal skin conditions. This spray form is applied directly to the skin. As an OTC monograph drug, it is marketed under FDA established rules for this category rather than through individual product approval.
Patient education
Supplement & herbal interactions
Some supplements/herbs that may interact with Undecylenic Acid — tap one for details:
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 53145-0319-02 You're viewing this Main listing | 1 BOTTLE, SPRAY in 1 CARTON / 30 mL in 1 BOTTLE, SPRAY | 2020-04-06 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Hongocura S 20 mg/100mLthis 53145-0319-02 | MENPER | 1 bottle | — | — | FDA listed | — |
| Hongocura M 20 mg/100mL 53145-0219-03 | MENPER | 1 bottle | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII ND2M416302
Isopropyl alcohol is a clear liquid solvent derived from petroleum. In medicines, it dissolves active ingredients and other components, helps the product flow smoothly, and aids in sterilization during manufacturing.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
2 inactive ingredients listed in the exact product block matched to this NDC.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from MENPER DISTRIBUTORS, INC. labeler code 53145
- Anestenka Benzocaine .2 mg/2mL Liquid NDC 53145-301-12
- Veneno de Abeja Aceite De Vibora Brand Methyl Salicylate 10.5 g/100g Ointment NDC 53145-303-05
- Polvos de Sulpha First Aid Antibiotic Bacitracin Zinc, Polymyxin B Sulfate 500 [USP'U]/g; 10000 [USP'U]/g Powder NDC 53145-304-04
- LIENDREX Pyrethrum extract, Piperonyl Butoxide 4 g/100mL; .3 g/100mL Shampoo NDC 53145-308-04
- Auralyt Carbamide Peroxide 7.8 mg/12mL Liquid NDC 53145-311-04
- BeeVenom Methyl Salicylate 10.5 g/100g Ointment NDC 53145-315-05
- Bisolvine Children Guaifenesin, Dextromethorphan 100 mg/15mL; 10 mg/15mL Liquid NDC 53145-322-04
- Adult Bisolvine Adult Guaifenesin, Dextromethorphan 20 mg/10mL; 200 mg/10mL Liquid NDC 53145-323-04
- Defensol-ito Dextromethorphan, Guiafenesin, Phenylephrine 4 mg/mL; 50 mg/mL; 2.5 mg/mL Solution NDC 53145-333-15
- Sodium Bicarbonate Antacid 2.616 g/2.616g Powder NDC 53145-390-04
- Bisolvine Aloe-Miel Dextromethorphan, Guaifenesin 10 mg/15mL; 100 mg/15mL Liquid NDC 53145-402-06
- Balsamo de Vaca Mascura Methyl Salicylate 10.5 g/100g Ointment NDC 53145-403-03
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Do not use on children Under 2 years of age, unless directed by a doctor for diaper rash Stop use and ask a doctor if Irritation occurs there is no improvement within 4 weeks When using this product Avoid contact with eyes and mucus membrane
⏱️ Dosage and Administration ▾
Directions clean the affected area and dry throughly apply a thin layer of Hongocura M Antifungal Spray over the affected area twice daily (morning and night) or as directed by a doctor supervise children in use of this product for athlete's foot: Pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily for athlete's foot and ringworm, use daily for 4 weeks. if condition persists longer, consult a doctor this product is not effective on the scalp or nails store between 15°-30°C(59°-86°F)
⚠️ Warnings ▾
Warnings For external use only. Flammable: Keep away from fire and flame. Do not use on children Under 2 years of age, unless directed by a doctor for diaper rash Stop use and ask a doctor if Irritation occurs there is no improvement within 4 weeks When using this product Avoid contact with eyes and mucus membrane
🧪 Active Ingredient ▾
Active Ingredient Purpose Undecylenic Acid 20% v/v.................Antifungal
🧪 Inactive Ingredients ▾
Inactive Ingredients isopropyl alcohol and water.
🎯 Purpose ▾
Purpose Antifungal
🤰 If Pregnant or Breast-Feeding ▾
If pregnant or breast-feeding, consult a doctor before use.
📄 Keep Out of Reach of Children ▾
Keep out of the reach of children. If swallowed, get medical help or contact a Posion Control Center right away.
📄 Questions or Comments ▾
Questions: 1-800-560-5223 Monday - Friday (9 AM - 4 PM EST) www.menperdistributors.com
📄 Package Label / Principal Display Panel ▾
Hongocuras
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |